Print
Category: Health News

Dallas, Texas - Blood glucose health is deteriorating in obese adults, despite overall progress in lowering blood pressure and cholesterol levels, which may raise the risk of Type 2 diabetes and cardiovascular complications, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

“The adverse impact of obesity on blood sugar status appears to develop over a longer period of time, and the population is still experiencing progressive worsening of glycemic status,” said Fangjian Guo, M.D., Ph.D., study co-author and assistant professor, Obstetrics & Gynecology at the University of Texas, in Galveston, Texas. “If blood sugar goes high too often, it can overwork the body’s ability to keep blood sugar in healthy ranges increasing the risk of developing diabetes complications.”

Diabetes is a risk factor for heart disease and stroke. Researchers analyzed data on more than 18,000 obese adults from the National Health and Nutrition Examination Survey for almost three decades.

They found:

“Diabetes places patients at very high risk for heart attack and coronary death,” said W. Timothy Garvey, M.D., study co-author and professor of medicine and chair of the Department of Nutrition Sciences at the University of Alabama in Birmingham.  “Obese adults at high risk for diabetes and heart disease may require more intense approaches to control blood sugar and achieve weight loss, such as healthy meal plans and physical activity.”

Obesity impairs the body’s ability to properly process blood sugar. Losing weight can reverse this effect. Researchers note that recent obesity rates have leveled off after three decades of steady climbing. Currently, more than one-third or about 35 percent of American adults are obese.

Researchers said their findings suggest controlling weight in obese adults to reduce the risk of developing of Type 2 diabetes should be a public health priority.

Author disclosures are on the manuscript.

The Merit Review program of the Department of Veterans Affairs, National Institutes of Health and the UAB Diabetes Research Center funded the study.